De-Risking Early Phase Development

Date: 8 July 2026 Venue: Parc Cientific de Barcelona, Sala Dolors Aleu

2026-07-01

CPHI South East Asia 2026

Date: 8-10 July 2026 Venue: 60 New Rachadapisek Road, Klongtoey, Bangkok, Thailand

2026-07-01

SynTech

Date: 6-8 July 2026 Venue: Old Royal Naval College, Greenwich, London, UK

2026-07-01

ISPC 2026

Date: 1-3 July 2026 Venue:Act City Hamamatsu, Hamamatsu City, Shizuoka Prefecture, Japan

2026-07-01

InterBiz Bio Partnering

Date: 1-3 July 2026 Venue: Phoenix Island Jeju, Building B, 107, Seopjikoji-ro, Seongsan-eup, Seogwipo-si, Jeju-do, Republic of Korea

2026-07-01

Peptide Technology Platforms Power the Next Wave of Therapeutic Innovation

The pharmaceutical industry is witnessing an unprecedented surge in peptide-based therapeutics, driven by their unique ability to combine the target specificity of biologics with the manufacturing efficiency of small molecules. As GLP-1 agonists and other peptide drugs achieve blockbuster success,

2026-06-29

Peptide Drug Development Accelerates as Next-Generation Therapeutics Reshape the Pharmaceutical Landscape

The global pharmaceutical landscape is being reshaped by the rising prominence of peptide-based therapeutics, driven by their success in treating chronic diseases such as diabetes, obesity, and cancer. As more peptide candidates enter clinical pipelines and gain regulatory approval,

2026-06-22

Small Molecule CDMO Services Drive Agility and Innovation in a Complex Drug Development Landscape

The global pharmaceutical industry is undergoing a profound shift, yet small molecule active pharmaceutical ingredients (APIs) remain the backbone of modern therapeutics. As drug pipelines grow more complex and the demand for targeted therapies rises, the strategic role of small molecule CDMO services has never been more critical. From early development to commercial supply, these services are enabling faster timelines, regulatory success, and supply chain resilience.

2026-06-15

A Nucleophilic catalysis reaction: Phosphine-catalyzed strain-release alkynylation of bicyclo [1.1.0] butanes

2026-06-11

Peptide Ingredients for Enhancing Skin Volume

GLP-1 agonists, like semaglutide and tirzepatide, improve blood sugar control and promote significant weight loss by enhancing insulin secretion, reducing appetite, and slowing gastric emptying. They may also provide cardiovascular risk reduction benefits in people with type-2 diabetes.

2026-06-08

World Environment Day | JiuZhou Pharma: Action for a Greener Planet

Green transformation: Not a choice, but a must. We walk the talk on low carbon, partner with our peers to protect our planet, and build a greener, healthier future. Driven by science and precision, we are accelerating, deepening and leading pharma's green transition.

2026-06-05

BIO International Convention

Date: 22-25 June 2026 Venue: San Diego Convention Center

2026-06-02